Proteomic approach to aging research

Expert Review of Proteomics

Volumn 4, Issue 2, 2007, Pages 309-321

  Sharov, Victor S ^a   Schöneich, Christian ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Biogerontology; Bioinformatics; Biomarker; Electrophoresis; High performance liquid chromatography; Mass spectrometry; Protein expression; Protein post translational modification; Proteomics

Indexed keywords

BIOLOGICAL MARKER; BRAIN PROTEIN; PROTEOME;

AGING; DIAGNOSTIC VALUE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SPACE; ISOTOPE LABELING; LIFESPAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEOMICS; REVIEW; SKELETAL MUSCLE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

AGING; BIOMEDICAL RESEARCH; HUMANS; PROTEINS; PROTEOMICS;

EID: 34247096944     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.4.2.309     Document Type: Review

References (93)

1. Service RF. Proteomics. Public projects gear up to chart the protein landscape. Science 302(5649), 1316-1318 (2003).
2. Pierce A, deWaal E, Van Remmen H et al. A novel approach for screening the proteome for changes in protein conformation. Biochemistry 45(9), 3077-3085 (2006).
3. Choi J, Forster MJ, McDonald SR et al. Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease. Free Radic. Biol. Med. 36(9), 1155-1162 (2004).
4. Soreghan BA, Lu BW, Thomas SN et al. Using proteomics and network analysis to elucidate the consequences of synaptic protein oxidation in a PS1 + aβPP mouse model of Alzheimer's disease. J. Alzheimers Dis. 8(3), 227-241 (2005).
5. Butterfield DA, Poon HF. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp. Gerontol. 40(10), 774-783 (2005). • Describes a common animal model to study age-related neurological disorders, which may be applied to proteomic studies of aging.
6. Poon HF, Shepherd HM, Reed TT et al. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis. Neurobiol. Aging 27(7), 1020-1034 (2005).
7. Li D, Sun F, Wang K. Protein profile of aging and its retardation by caloric restriction in neural retina. Biochem. Biophys. Res. Commun. 318(1), 253-258 (2004).
8. 18O labeling and the accurate mass and time tag approach. Mol. Cell. Proteomics 4(5), 700-709 (2005). • Demonstrating a potential of high-throughput mass spectrometry (MS) technology for quantitative global proteomic analysis of human blood plasma.
9. Gromov PS, Ostergaard M, Gromova I, Celis JE. Human proteomic databases: a powerful resource for functional genomics in health and disease. Prog. Biophys. Mol. Biol. 80(1-2), 3-22 (2002).
10. Titz B, Schlesner M, Uetz P. What do we learn from high-throughput protein interaction data? Expert Rev. Proteomics 1(1), 111-121 (2004).
11. Baldwin KM. Research in the exercise sciences: where do we go from here? J. Appl. Physiol. 88(1), 332-336 (2000).
12. Blagoev B, Kratchmarova I, Ong SE et al. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotech. 21(3), 315-318 (2003).
13. Abbott A. Brain protein project enlists mice in 'dry run'. Nature 425(6954), 110 (2003).
14. Chen W, Ji J, Xu X et al. Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins. Int. J. Dev. Neurosci. 21(4), 209-216 (2003).
15. Korolainen MA, Auriola S, Nyman TA et al. Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain. Neurobiol. Dis. 20(3), 858-870 (2005).
16. Porchet R, Probst A, Bouras C et al. Analysis of glial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease. Proteomics 3(8), 1476-1485 (2003).
17. Cobon GS, Verrills N, Papakostopoulos P et al. The proteomics of ageing. Biogerontology 3(1-2), 133-136 (2002).
18. Gromov P, Skovgaard GL, Palsdottir H et al. Protein profiling of the human epidermis from the elderly reveals up-regulation of a signature of interferon-γ-induced polypeptides that includes manganese-superoxide dismutase and the p85β subunit of phosphatidylinositol 3-kinase. Mol. Cell. Proteomics 2(2), 70-84 (2003). • One of the pioneering gel-based proteomics studies using tissue biopsies from human skin of young and old individuals. The study provides insight into the major protein changes during human epidermal aging in vivo.
19. Zhang J, Goodlett DR, Peskind ER et al. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol. Aging 26(2), 207-227 (2005).
20. Yan L, Ge H, Li H et al. Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. J. Mol. Cell Cardiol. 37(5), 921-929 (2004).
21. Poon HF, Castegna A, Farr SA et al. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 126(4), 915-926 (2004).
22. Poon HF, Farr SA, Banks WA et al. Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the aβ region of amyloid precursor protein. Brain Res. Mol. Brain Res. 138(1), 8-16 (2005).
23. Poon HF, Farr SA, Thongboonkerd V et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with α-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem. Int. 46(2), 159-168 (2005).
24. Poon HF, Vaishnav RA, Getchell TV et al. Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice. Neurobiol. Aging 27(7), 1010-1019 (2005).
25. Marzban G, Grillari J, Reisinger E et al. Age-related alterations in the protein expression profile of C57Bl/6j mouse pituitaries. Exp. Gerontol. 37(12), 1451-1460 (2002).
26. Soreghan BA, Yang F, Thomas SN et al. High-throughput proteomic-based identification of oxidatively induced protein carbonylation in mouse brain. Pharm. Res. 20(11), 1713-1720 (2003). • Describes a rapid and sensitive proteomic analysis for the identification of carbonylated proteins in mouse brain homogenates through the conjunction of liquid chromatography and tandem MS coupled to selective affinity enrichment of post-translational modifications (PTMs).
27. Tsugita A, Kawakami T, Uchida T et al. Proteome analysis of mouse brain: two-dimensional electrophoresis profiles of tissue proteins during the course of aging. Electrophoresis 21(9), 1853-1871 (2000). • One of the pioneer proteomic studies on animal aging.
28. Gelfi C, Vigano A, De Palma S et al. 2-D protein maps of rat gastrocnemius and soleus muscles: a tool for muscle plasticity assessment. Proteomics 6(1), 321-340 (2006).
29. Kanski J, Alterman MA, Schöneich C. Proteomic identification of age-dependent protein nitration in rat skeletal muscle. Free Radic. Biol. Med. 35(10), 1229-1239 (2003).
30. Kanski J, Hong SJ, Schöneich C. Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine- containing sequences in vivo by nanoelectrospray ionization tandem mass spectrometry. J. Biol. Chem. 280(25), 24261-24266 (2005). • Demonstrated that use of solution isoelectric focusing (IEF) as a first dimension of 2D gel electrophoresis (2DE) proteomics analysis facilitates the detection of protein PTMs (3-nitrotyrosine) in samples from animal tissues.
31. Piec I, Listrat A, Alliot J et al. Differential proteome analysis of aging in rat skeletal muscle. FASEB J. 19(9), 1143-1145 (2005).
32. Kanski J, Behring A, Pelling J, Schöneich C. Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: effects of biological aging. Am. J. Physiol. Heart Circ. Physiol. 288(1), H371-H381 (2005).
33. Jager D, Holtz J, Redpath NT et al. The ageing heart: influence of cellular and tissue ageing on total content and distribution of the variants of elongation factor-2. Mech. Ageing Dev. 123(10), 1305-1319 (2002).
34. Ueda Y, Duncan MK, David LL. Lens proteomics: the accumulation of crystallin modifications in the mouse lens with age. Invest. Ophthalmol. Vis. Sci. 43(1), 205-215 (2002).
35. Cho YM, Bae SH, Choi BK et al. Differential expression of the liver proteome in senescence accelerated mice. Proteomics 3 (10), 1883-1894 (2003).
36. Kim CH, Zou Y, Kim DH et al. Proteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging. J. Gerontol. A Biol. Sci. Med. Sci. 61(4), 332-338 (2006).
37. Boraldi F, Bini L, Liberatori S et al. Proteome analysis of dermal fibroblasts cultured in vitro from human healthy subjects of different ages. Proteomics 3(6), 917-929 (2003).
38. Dahl A, Eriksson PS, Persson AI et al. Proteome analysis of conditioned medium from cultured adult hippocampal progenitors. Rapid Commun. Mass Spectrom. 17(19), 2195-2202 (2003).
39. Dierick JF, Eliaers F, Remacle J et al. Stress-induced premature senescence and replicative senescence are different phenotypes, proteomic evidence. Biochem. Pharmacol. 64(5-6), 1011-1017 (2002).
40. Galvin JE, Ginsberg SD. Expression profiling in the aging brain: a perspective. Ageing Res. Rev. 4(4), 529-547 (2005).
41. Jin K, Mao XO, Cottrell B et al. Proteomic and immunochemical characterization of a role for stathmin in adult neurogenesis. FASEB J. 18(2), 287-299 (2004).
42. Lee JH, Chung KY, Bang D, Lee KH. Searching for aging-related proteins in human dermal microvascular endothelial cells treated with anti-aging agents. Proteomics 6(4), 1351-1361 (2006).
43. Park SY, Lee S, Park KS et al. Proteomic analysis of cellular change involved in mitochondria-to-nucleus communication in L6 GLUT4myc myocytes. Proteomics 6(4), 1210-1222 (2006).
44. Poggioli S, Mary J, Bakala H, Friguet B. Evidence of preferential protein targets for age-related modifications in peripheral blood lymphocytes. Ann. NY Acad. Sci. 1019, 211-214 (2004).
45. Rime H, Guitton N, Pineau C et al. Post-ovulatory ageing and egg quality: a proteomic analysis of rainbow trout coelomic fluid. Reprod. Biol. Endocrinol. 2, 26 (2004).
46. Visala Rao D, Boyle GM, Parsons PG et al. Influence of ageing, heat shock treatment and in vivo total antioxidant status on gene-expression profile and protein synthesis in human peripheral lymphocytes. Mech. Ageing Dev. 124(1), 55-69 (2003).
47. 2 stress from human diploid fibroblasts. Mol. Cell. Proteomics 4(9), 1273-1283 (2005).
48. Chang J, Van Remmen H, Cornell J et al. Comparative proteomics: Characterization of a two-dimensional gel electrophoresis system to study the effect of aging on mitochondrial proteins. Mech. Ageing Dev. 124(1), 33-41 (2003).
49. Da Cruz S, Parone PA, Martinou JC. Building the mitochondrial proteome. Expert Rev. Proteomics 2(4), 541-551 (2005).
50. Mao L, Zabel C, Wacker MA et al. Estimation of the mtDNA mutation rate in aging mice by proteome analysis and mathematical modeling. Exp. Gerontol. 41(1), 11-24 (2006).
51. Coute Y, Burgess JA, Diaz JJ et al. Deciphering the human nucleolar proteome. Mass Spectrom. Rev. 25(2), 215-234 (2006).
52. Caldwell RL, Caprioli RM. Tissue profiling by mass spectrometry: a review of methodology and applications. Mol. Cell. Proteomics 4(4), 394-401 (2005).
53. Standaert DG. Applications of laser capture microdissection in the study of neurodegenerative disease. Arch. Neurol. 62(2), 203-205 (2005).
54. Somiari RI, Somiari S, Russell S, Shriver CD. Proteomics of breast carcinoma. J. Chromatogr. B 815(1-2), 215-225 (2005).
55. Toda T. Proteome and proteomics for the research on protein alterations in aging. Ann. NY Acad. Sci. 928, 71-78 (2001).
56. Dierick JF, Dieu M, Remacle J et al. Proteomics in experimental gerontology. Exp. Gerontol. 37(5), 721-734 (2002).
57. Schöneich C. Proteomics in gerontological research. Exp. Gerontol. 38(5), 473-481 (2003).
58. Gafni A. Proteomics in aging-related research. Sci. Aging Knowledge Environ. 45, pe41 (2004).
59. Lubman DM, Kachman MT, Wang H et al. Two-dimensional liquid separations - mass mapping of proteins from human cancer cell lysates. J. Chromatogr. B 782(1-2), 183-196 (2002). • Demonstrated that reverse-phase high-performance liquid chromatography may be an alternative to IEF as a first dimension of proteomic analysis, particularly for membrane proteins
60. Sharov VS, Galeva NA, Knyushko TV et al. Two-dimensional separation of the membrane protein sarcoplasmic reticulum ca-ATPase for high-performance liquid chromatography-tandem mass spectrometry analysis of posttranslational protein modifications. Anal. Biochem. 308(2), 328-335 (2002).
61. Dremina ES, Sharov VS, Schöneich C. Protein tyrosine nitration in rat brain is associated with raft proteins, flotillin-1 and α-tubulin: effect of biological aging. J. Neurochem. 93(5), 1262-1271 (2005).
62. Kanski J, Schöneich C. Protein nitration in biological aging: proteomic and tandem mass spectrometric characterization of nitrated sites. Meth. Enzymol. 396, 160-171 (2005).
63. Patton WF. Detection technologies in proteome analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 771(1-2), 3-31 (2002).
64. Mirzaei H, Regnier F. Affinity chromatographic selection of carbonylated proteins followed by identification of oxidation sites using tandem mass spectrometry. Anal. Chem. 77(8), 2386-2392 (2005).
65. Nakata K, Crabb JW, Hollyfield JG. Crystallin distribution in Bruch's membrane-choroid complex from AMD and age-matched donor eyes. Exp. Eye Res. 80(6), 821-826 (2005).
66. Toda T. Current status and perspectives of proteomics in aging research. Exp. Gerontol. 35(6-7), 803-810 (2000).
67. Tuttle JL, Hahn TL, Sanders BM et al. Impaired collateral development in mature rats. Am. J. Physiol. Heart Circ. Physiol. 283(1), H146-H155 (2002).
68. Poon HF, Vaishnav RA, Butterfield DA et al. Proteomic identification of differentially expressed proteins in the aging murine olfactory system and transcriptional analysis of the associated genes. J. Neurochem. 94(2), 380-392 (2005).
69. Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 382(3), 669-678 (2005). • Demonstrates advantages of 2DE difference gel electrophoresis for quantitative proteomic analysis.
70. Monteoliva L, Albar JP. Differential proteomics: an overview of gel and non-gel based approaches. Brief. Funct. Genomic. Proteomic. 3(3), 220-239 (2004).
71. Wheelock ÅM, Morin D, Bartosiewicz M, Buckpitt AR. Use of a fluorescent internal protein standard to achieve quantitative two-dimensional gel electrophoresis. Proteomics 6(5), 1385-1398 (2006).
72. Friedman DB, Hill S, Keller JW et al. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4(3), 793-811 (2004).
73. Gharbi S, Gaffney P, Yang A et al. Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell. Proteomics 1(2), 91-98 (2002).
74. Steinberg TH, Agnew BJ, Gee KR et al. Global quantitative phosphoprotein analysis using multiplexed proteomics technology. Proteomics 3(7), 1128-1144 (2003). • Extensive review on global quantitative protein phosphorylation proteomic analysis.
75. Hensley K, Floyd RA. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch. Biochem. Biophys. 397(2), 377-383 (2002).
76. Gow AJ, Farkouh CR, Munson DA et al. Biological significance of nitric oxide-mediated protein modifications. Am. J. Physiol. Lung Cell Mol. Physiol. 287(2), L262-L268 (2004).
77. Stamler JS, Lamas S, Fang FC. Nitrosylation: the prototypic redox-based signaling mechanism. Cell 106 (6), 675-683 (2001).
78. Barrett DM, Black SM, Todor H et al. Inhibition of protein-tyrosine phosphatases by mild oxidative stresses is dependent on S-nitrosylation. J. Biol. Chem. 280 (15), 14453-14461 (2005).
79. Clavreul N, Adachi T, Pimental DR et al. S-glutathiolation by peroxynitrite of p21ras at cysteine-118 mediates its direct activation and downstream signaling in endothelial cells. FASEB J. 20(3), 518-520 (2006).
80. Sharov VS, Galeva NA, Kanski J et al. Age-associated tyrosine nitration of rat skeletal muscle glycogen phosphorylase b: characterization by HPLC-nanoelectrospray-tandem mass spectrometry. Exp. Gerontol. 41(4), 407-416 (2006).
81. Crabb JW, Miyagi M, Gu X et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl Acad. Sci. USA 99(23), 14682-14687 (2002).
82. Miura Y, KanoM, Abe K et al. Age-dependent variations of cell response to oxidative stress: proteomic approach to protein expression and phosphorylation. Electrophoresis 26(14), 2786-2796 (2005).
83. Kislinger T, Gramolini AO, MacLennan DH, Emili A. Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. J. Am. Soc. Mass Spectrom. 16(8), 1207-1220 (2005).
84. Qian W-J, Camp II DJ, Smith RD. High-throughput proteomics using Fourier transform ion cyclotron resonance mass spectrometry. Expert Rev. Proteomics 1(1), 87-95 (2004).
85. Domon B, Aebersold R. Mass spectrometry and protein analysis. Science 312(5771), 212-217 (2006).
86. Mirzaei H,Regnier F. Enrichment of carbonylated peptides using Girard P reagent and strong cation exchange chromatography. Anal. Chem. 78(3), 770-778 (2006).
87. Sacksteder CA, Qian WJ, Knyushko TV et al. Endogenously nitrated proteins in mouse brain: links to neurodegenerative disease. Biochemistry 45(26), 8009-8022 (2006).
88. Krijgsveld J, Ketting RF, Mahmoudi T et al. Metabolic labeling of C. elegans and D. melanogaster for quantitative proteomics. Nat. Biotech. 21(8), 927-931 (2003).
89. Wu CC, MacCoss MJ, Howell KE et al. Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal. Chem. 76(17), 4951-4959 (2004). •• Outlines the first instance of metabolic protein stable isotope labeling in a mammalian organism for quantitative proteomic analysis.
90. Doherty MK, Beynon RJ. Protein turnover on the scale of the proteome. Expert Rev. Proteomics 3(1), 97-110 (2006).
91. Rattan SI, Gonzalez-Dosal R, Nielsen ER et al. Slowing down aging from within: mechanistic aspects of anti-aging hormetic effects of mild heat stress on human cells. Acta Biochim. Pol. 51(2), 481-492 (2004).
92. Schöneich C. Mass spectrometry in aging research. Mass Spectrom. Rev. 24(5), 701-718 (2005).
93. Genomic BLAST with microbial genomes www.ncbi.nlm.nih.gov/sutils/ genom_table.cgi